- Home
- BBIO vs SKYW Comparison
BBIO vs SKYW Comparison
Compare BBIO & SKYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- SKYW
- Stock Information
- Founded
- BBIO 2015
- SKYW 1972
- Country
- BBIO United States
- SKYW United States
- Employees
- BBIO N/A
- SKYW N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- SKYW Air Freight/Delivery Services
- Sector
- BBIO Health Care
- SKYW Consumer Discretionary
- Exchange
- BBIO Nasdaq
- SKYW Nasdaq
- Market Cap
- BBIO 5.1B
- SKYW 4.3B
- IPO Year
- BBIO 2019
- SKYW N/A
- Fundamental
- Price
- BBIO $26.49
- SKYW $101.83
- Analyst Decision
- BBIO Strong Buy
- SKYW Buy
- Analyst Count
- BBIO 13
- SKYW 4
- Target Price
- BBIO $47.92
- SKYW $105.75
- AVG Volume (30 Days)
- BBIO 2.7M
- SKYW 398.6K
- Earning Date
- BBIO 11-12-2024
- SKYW 01-30-2025
- Dividend Yield
- BBIO N/A
- SKYW N/A
- EPS Growth
- BBIO N/A
- SKYW N/A
- EPS
- BBIO N/A
- SKYW 5.85
- Revenue
- BBIO $217,765,000.00
- SKYW $3,335,305,000.00
- Revenue This Year
- BBIO $2,648.47
- SKYW $21.31
- Revenue Next Year
- BBIO N/A
- SKYW $8.57
- P/E Ratio
- BBIO N/A
- SKYW $17.40
- Revenue Growth
- BBIO 2209.77
- SKYW 16.42
- 52 Week Low
- BBIO $21.62
- SKYW $48.28
- 52 Week High
- BBIO $44.32
- SKYW $117.51
- Technical
- Relative Strength Index (RSI)
- BBIO 49.05
- SKYW 39.82
- Support Level
- BBIO $25.34
- SKYW $98.37
- Resistance Level
- BBIO $28.15
- SKYW $110.43
- Average True Range (ATR)
- BBIO 1.33
- SKYW 3.67
- MACD
- BBIO -0.24
- SKYW -1.57
- Stochastic Oscillator
- BBIO 24.73
- SKYW 17.40
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About SKYW SkyWest Inc.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines and SkyWest Leasing.